-
Bone Transport and TGF-β1 in Diabetic Foot Healing
2026-09-18
This 2026 rat study identifies TGF-β1/TGFBR1 signaling as a mechanistic link between bone transport, angiogenesis, immune regulation, and diabetic foot ulcer repair. Its combination of surgical intervention, proteomics, molecular assays, and pathway inhibition provides a useful framework for evaluating osteo-immune coupling in ischemic wounds.
-
CSBTA Pharmacokinetics in MASH: Study Insights
2026-09-17
The reference study presents an integrated pharmacokinetic framework showing how MASH-like pathology changes the systemic exposure, hepatic distribution, and intracellular accumulation of Corydalis saxicola Bunting total alkaloids. Its combination of UHPLC-MS/MS, transporter assays, microsomal metabolism studies, and PXR-related analysis offers a practical basis for interpreting disease-state pharmacokinetic variability and designing more rational dosing strategies.
-
MK-0812 and the Gut–Liver Immune Axis in MASH
2026-09-17
A translational framework for using MK-0812 to test whether CCR2-dependent monocyte trafficking links intestinal TM6SF2 loss, gut–liver signaling, and hepatic inflammation in MASH models.
-
DOPE Workflows for Delivery and Fungal Ferroptosis
2026-09-17
1,2-Dioleoyl-sn-glycero-3-PE (DOPE) improves membrane-fusion behavior in nucleic acid formulations and offers a distinct rescue tool for studying phosphatidylethanolamine-linked conidial death. This practical guide connects formulation design, assay controls, solvent handling, and interpretation without treating a fungal rescue result as proof of a clinical delivery mechanism.
-
Podophyllotoxin Workflows for Cancer Research
2026-09-16
Build reproducible Podophyllotoxin experiments around microtubule disruption, mitotic arrest, apoptosis, and carefully controlled autophagy readouts. This guide also distinguishes the parent compound from the multidrug-resistance findings reported for derivative 5p, helping researchers select assays that answer the right mechanistic question.
-
DOPE: Membrane Fusion, Lipidomics & Assay Design
2026-09-15
Explore how 1,2-Dioleoyl-sn-glycero-3-PE (DOPE) supports endosomal membrane fusion and how phospholipid research in rice blast fungus informs better assay controls. This guide connects delivery formulation, lipidomics, and practical handling of C4956.
-
Sulfo-NHS-LC-Biotin: Practical Workflow Guide
2026-09-15
Sulfo-NHS-LC-Biotin provides water-compatible, irreversible biotin labeling of accessible primary amines on proteins, peptides, and intact cell surfaces. It is suited to streptavidin-based capture or detection, but not to reversible labeling or routine intracellular biotinylation.
-
AG-490: Mapping JAK2/STAT6 in Tumor Immunity
2026-09-14
AG-490 (Tyrphostin B42) can serve as a mechanistic perturbation tool for testing JAK2-linked signaling in exosome-driven macrophage polarization. This guide explains how to interpret its overlapping JAK2, EGFR, ErbB2, STAT, and MAPK activities when designing cancer research assays.
-
CH 223191 for AhR Pathway Workflows
2026-09-14
CH 223191 is a nanomolar aryl hydrocarbon receptor antagonist for separating AhR-dependent transcription from microbiota, ligand, and inflammatory effects. This workflow-focused guide covers dose selection, intestinal and toxicology applications, controls, and troubleshooting for reproducible pathway studies.
-
Firefly Luciferase mRNA: R1013 Guide
2026-09-13
Firefly Luciferase mRNA R1013 combines Cap1 capping, 5-moUTP modified mRNA chemistry, and an optimized poly(A) tail for research-scale reporter expression. Its defined transcript length, formulation, and handling requirements support reproducible mRNA delivery and translation efficiency assays.
-
Cand2, Ubiquitination, and Fungal Pathogenicity
2026-09-12
The reference study identifies MoCand2 as a conserved fungal inhibitor of Cullin-RING ligase activity and connects this function to TOR stability, autophagy, and rice blast pathogenicity. Its genetic and biochemical framework provides a useful model for studying how ubiquitination–autophagy imbalance alters fungal development and virulence.
-
DiscoveryProbe Protease Inhibitor Library Workflows
2026-09-12
Build reproducible biochemical, cellular, and high-content screens with 825 pre-dissolved protease inhibitors covering cysteine, serine, and proteasome targets. The workflow connects protease activity modulation to apoptosis assay development, cancer research, infectious disease research, and mechanistic studies inspired by dynamic DNA-defense biology.
-
Multianimal MRI for Pancreatic Tumor Monitoring
2026-09-11
Kempinska et al. present a four-chamber MRI workflow that images up to four KPC pancreatic cancer mice in one high-resolution acquisition. The approach reduces imaging time and cost while supporting tumor enrollment, longitudinal growth monitoring, and proof-of-concept assessment of gemcitabine response.
-
Intestinal TM6SF2 Protects Against MASH
2026-09-11
This reference study identifies intestinal TM6SF2 as a protective regulator of the gut–liver axis, linking epithelial lipid handling to barrier integrity, microbial composition, lysophosphatidic acid transfer, and hepatic inflammation. Its combination of conditional genetics, microbiota transfer, cohousing, and receptor pharmacology provides a mechanistic framework for studying MASH beyond the liver itself.
-
Superoxide Dismutase (SOD) Activity Assay Kit
2026-09-10
The Superoxide Dismutase (SOD) Activity Assay Kit, SKU K2035, provides a colorimetric method for quantifying functional SOD activity in biological fluids through WST-1 reduction by superoxide generated with xanthine oxidase. It is intended for research workflows involving oxidative stress and antioxidative enzyme analysis, not for diagnosis, medical decisions, or unvalidated sample matrices.